Document Detail


Low-dose aspirin (ASA) renders human platelets more vulnerable to inhibition of aggregation by prostacyclin (PGI2).
MedLine Citation:
PMID:  6348804     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Pre-treatment of human, platelet-rich plasma with concentrations of aspirin that produced 50% or less inhibition of aggregation induced by collagen, arachidonic acid or adenosine diphosphate, significantly increased the % inhibition of platelet aggregation by a low concentration of authentic prostacyclin or by prostacyclin-like activity generated by incubation of rat aorta rings in human platelet-poor plasma. Similarly a single aspirin tablet (325 mg) taken orally by human volunteers significantly increased the sensitivity of their platelets to inhibition of aggregation by authentic prostacyclin (8.1 X 10(-10) M) for 2-48 h after ingestion. Statistical significance was lost at 72 h but the trend was still evident. These results support the contention that low doses of aspirin may be efficacious in the therapy of arterial thromboembolism since this could preserve some arterial prostacyclin-generating activity which might be sufficient to inhibit adhesion and aggregation of the aspirin-treated platelets.
Authors:
R B Philp; M L Paul
Related Documents :
7003384 - Inhibition of prostacyclin and platelet thromboxane a2 after low-dose aspirin.
18175654 - Aspirin resistance.
11675854 - Antiplatelet agents for secondary prevention of ischemic stroke.
1939654 - Inhibition of platelet function by an aspirin-insensitive endothelial cell adpase. thro...
11325244 - Additional bioactive lyso-paf congeners from the sponge spirastrella abata.
704904 - Preparation of some prostaglandin e1 and omega-homo-prostaglandin e1 esters and their i...
Publication Detail:
Type:  Comparative Study; In Vitro; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Prostaglandins, leukotrienes, and medicine     Volume:  11     ISSN:  0262-1746     ISO Abbreviation:  Prostaglandins Leukot Med     Publication Date:  1983 Jun 
Date Detail:
Created Date:  1983-09-23     Completed Date:  1983-09-23     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8206868     Medline TA:  Prostaglandins Leukot Med     Country:  SCOTLAND    
Other Details:
Languages:  eng     Pagination:  131-42     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Animals
Aorta / metabolism
Aspirin / administration & dosage,  blood,  pharmacology*
Drug Synergism
Epoprostenol / biosynthesis,  pharmacology*
Female
Humans
Male
Middle Aged
Platelet Aggregation / drug effects*
Prostaglandins / pharmacology*
Rats
Rats, Inbred Strains
Thromboembolism / drug therapy
Chemical
Reg. No./Substance:
0/Prostaglandins; 35121-78-9/Epoprostenol; 50-78-2/Aspirin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Plasma levels of 6-keto-prostaglandin F1 alpha in normotensive subjects and patients with essential ...
Next Document:  Reduced urinary excretion of prostaglandin E in essential hypertension.